Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,153	1,376	719	489	449	564
Market Cap Growth	-	91.39%	47.13%	8.83%	-20.35%	-
Enterprise Value	1,175	1,398	610	365	268	451
PE Ratio	-8.42	-8.42	-5.30	-5.82	-4.35	-10.73
PS Ratio	6.19	7.38	9.33	25.53	-	-
PB Ratio	4.64	5.53	5.06	4.07	2.61	4.33
P/FCF Ratio	-19.37	-19.37	-5.97	-19.72	-5.03	-14.22
P/OCF Ratio	-19.40	-19.40	-5.98	-3.68	-5.04	-14.32
EV/Sales Ratio	6.31	7.50	7.91	19.06	-	-
EV/EBITDA Ratio	-10.29	-10.29	-4.98	-5.58	-2.62	-8.63
EV/EBIT Ratio	-9.49	-9.49	-4.84	-5.50	-2.60	-8.58
EV/FCF Ratio	-19.67	-19.67	-5.06	-14.72	-3.00	-11.37
Debt / Equity Ratio	1.24	1.24	1.00	1.10	0.30	0.03
Debt / EBITDA Ratio	-2.27	-2.27	-1.16	-2.03	-0.50	-0.07
Debt / FCF Ratio	-4.34	-4.34	-1.18	-5.35	-0.57	-0.09
Quick Ratio	4.07	4.07	4.26	6.10	12.56	8.92
Current Ratio	4.45	4.45	2.94	3.91	12.80	9.13
Asset Turnover	0.36	0.36	0.24	0.08	0	0
Interest Coverage	-9.75	-9.75	-7.89	-3.77	-307.25	-
Return on Equity (ROE)	-88.60%	-88.60%	-102.20%	-82.70%	-70.70%	-96.20%
Return on Assets (ROA)	-31.50%	-31.50%	-42.00%	-33.60%	-58.10%	-45.60%
Return on Capital (ROIC)	-19.60%	-19.60%	-46.11%	-68.61%	-46.77%	-40.85%
Earnings Yield	-14.17%	-11.88%	-18.87%	-17.19%	-23.00%	-9.32%
FCF Yield	-6.16%	-5.16%	-16.75%	-5.07%	-19.89%	-7.03%
Buyback Yield / Dilution	-20.31%	-20.31%	-12.07%	-20.08%	-119.84%	-
Total Shareholder Return	-20.31%	-20.31%	-12.07%	-20.08%	-119.84%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).